In California, faceoff between major insurer and health system shows hazards of consolidation

For weeks, more than half a million Anthem Blue Cross enrollees who receive health care from the University of California were held in suspense.

Astellas withdraws lawsuit after evading Medicare drug price negotiations

WASHINGTON — Astellas was so sure that one of its drugs was going to be selected as part of Medicare’s new drug price negotiation program

September 6, 2023

Think Twice Before Excising Bursa in Shoulder Surgery

Shoulder bursal tissue is often removed during rotator cuff repair, but that might not be such a good idea, researchers said. Studies with human bursa

April 25, 2024

Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission – Biotech Investments

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU)

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.